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Abstract
The aim of this work was to understand the crystallization process of terfenadine in solution.
Cooling of saturated solutions prepared at 50 ◦C at different temperatures, evaporating the solvent from nearly saturated solutions at a certain
temperature, and exposing ethanol solutions of terfenadine to water vapour atmosphere were the techniques used for obtaining terfenadine
specimens. The characterization of these specimens was carried out by thermal microscopy, differential thermal analysis, thermogravimetry
and powder X-ray diffraction. Crystalline phases, amorphous solids, and solvates were identified. For the solvents used in the present study, the
crystallinity degree of terfenadine decreases from ethanol–water to ethanol and from this to methanol. Decreasing the temperature promotes
the formation of amorphous solid material; at low temperatures, methanol and ethanol solvates are also formed.
Desolvation, following the terfenadine aggregation process in solution accounts for the different behaviour found for the solvents and for
the effect of temperature on the structure. The role of the solvent as structure-mediator is explained on the grounds of the values previously
published for the enthalpy of solution of terfenadine in the solvents under study.
© 2003 Elsevier B.V. All rights reserved.
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1. Introduction
Polymorphism became an emerging research field after
discovering that structural modifications of organic medic-
inal compounds give rise to different properties such as
bioavailability, morphology and stability [1,2]. Since then,
the pharmaceutical industry carries out research on poly-
morphism of drugs in order to offer increasingly efficient
medicines and to gain control over the preparation of solids
with desired physical properties [3,4].
As solvents play an important role in the structure of
solids in the crystallization process, this technique is a
common way for preparing polymorphs [4]. However, it is
not a straightforward method for getting single forms as,
besides the stable solid compatible with the experimental
conditions, often disordered material is precipitated from
solvents jointly with crystalline state phase. This proves
that crystallization in solution is a very complex process
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deserving much attention owing to its importance in crystal
engineering [5,6].
Most of the work performed on the preparation of poly-
morphs by crystallization in solution is concerned with
the characterization of the solid structures formed in a
given solvent under specified conditions. To overstep such
trial-and-error procedure, it is essential to establish guide-
lines leading to desired polymorphic forms. To reach this
stage, we need to understand crystallization at molecular
level of different types of solutes in different solvents under
several experimental conditions.
Solution calorimetry is a privileged research method for
understanding the crystallization in solution. Indeed, valu-
able information regarding the role played by the solvent and
the molecular aggregation processes can be drawn from the
enthalpy of solution at infinite dilution and from the variation
of the enthalpy with the concentration. The former property
is related with the solute solvation and the later with the in-
teraction between the solute molecules from monomers to
the solidification critical nucleus.
As embryo of the emergent new phase the structure of the
nucleus is determinant of that of the solid.
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A rather comprehensive work on polymorphism of terfe-
nadine was recently carried out by the authors of the present
paper. Four polymorphs were defined in specimens pre-
pared from ethanol, methanol and ethanol–water under dif-
ferent temperatures after being submitted to thermal curing
at 100 ◦C [7].
The aim of the present work is the interpretation of the
crystallization of terfenadine in different solvents and at
different temperatures on the grounds of thermodynamic
properties. The specimens obtained were characterized by
hot-stage microscopy, differential thermal analysis, thermo-
gravimetry and X-ray powder diffractometry and the results
interpreted on physical chemical grounds.
Terfenadine, 1-(4-tert-butylphenyl)-4-[4′-(diphenyl-hyd-
roxymethyl)-1′-piperidyl]butan-1-ol, is a non-sedating an-
tihistamine drug compound included in the polymorphism
research activity of our group [8,9].
Research in 1990s on polymorphism of terfenadine ob-
tained from crystallization in solution led to conclusion that
this compound in solid state can be present in two or three
structural modification [10–15].
2. Materials and methods
2.1. Chemicals
Terfenadine commercialized by Sigma–Aldrich was the
original material used for preparing the specimens under
consideration. A preliminary differential scanning calori-
metric test performed on the commercial product showed a
single fusion peak characterized by Tonset = 149.7±0.43 ◦C,
Tpeak = 150.4± 0.30 ◦C and width-half-maximum of 0.9±
0.02 ◦C. The comparison of these features with the data ob-
tained for terfenadine in previous studies leads to the conclu-
sion that the substance is a high melting polymorphic form
[7].
Methanol and ethanol (Merck Uvasol grade) used as
solvent were kept and handled with care in order to avoid
contamination with water vapour during storage and exper-
imental procedure.
2.2. Crystallization procedures
Supersaturation was generated by slow evaporation of the
solvent from a saturated solution of terfenadine or by cool-
ing, at different temperatures, a nearly saturated solution at
50 ◦C. Besides these techniques, terfenadine specimens were
prepared by water vapour diffusion into an ethanol solution.
An ethanol solution of terfenadine was maintained at 20 ◦C
in a tightly closed vessel containing a 1:1 water–alcohol
mixture. As the terfenadine is almost insoluble in water, the
uptake of water vapour by the solution gives rise to the solid
phase.
The methods used for preparing the specimens are sum-
marized in Table 1. The solid was separated from the liquid,
Table 1
Methods used in the preparation of terfenadine crystallized from solution
Specimena Solvent Method
E1 Ethanol Solvent evaporation at 50 ◦C
E2 Ethanol Solvent evaporation at 20 ◦C
E2′ Ethanol Cooling at 20 ◦C
E3 Ethanol Cooling at 3 ◦C
E4 Ethanol Cooling at −5 ◦C
M1 Methanol Solvent evaporation at 50 ◦C
M2 Methanol Solvent evaporation at 20 ◦C
M2′ Methanol Cooling at 20 ◦C
M3 Methanol Cooling at 3 ◦C
M4 Methanol Cooling at −5 ◦C
E–W3 Ethanol:water
(4:1, v/v)
Cooling at 20 ◦C
E–Wv Ethanol:water
(1:1, v/v)
Vapour diffusion at 20 ◦C
a Capital letters stand for solvent and numbers denote the temperature
at which crystallization was undertaken. The prime is used when two
specimens were prepared at the same temperature.
dried at 40 ◦C under vacuum for 48 h and kept in a desicca-
tor.
2.3. Instruments
Hot-stage, Mettler FP84HT TA, connected to FP900
control unit was the thermal equipment used in thermomi-
croscopy. This equipment allows the recording of DTA
curves during thermal cycles simultaneously with micro-
scopic observation.
Temperature readings of the control unit were checked
by determining the melting point of benzophenone (Mettler
Toledo Calibration Substance ME 18′870, Tfus = 48.1 ±
0.2 ◦C) and benzoic acid (Mettler Toledo Calibration Sub-
stance ME 18′555, Tfus = 122.3±0.2 ◦C). The readings ob-
tained for these standards were 48.1±0.2 and 122.4±0.2 ◦C,
respectively.
The optical equipment attached to the hot-stage system
consists of a DMRB Leica microscope equipped with polar-
ized light facilities, to which a Sony image processing as-
sembly composed of a CCD video camera (Sony DXC-151
AP), video tape recorder (Sony SVO-1500P VHS VCR),
colour video monitor (Sony PVM-2053 MD) and colour
video printer (Sony UP-1200 RP) were attached. A digital
video capturing equipment on computer, Studio DC10 Plus
from Pinacle Systems, was used for editing the image. Im-
age frame grabber permitted collection of individual images
to give details of particular aspects to be studied.
The thermal program for the microscopic examination
was run at heating rates between 10 and 1 ◦C/min. The
samples under observation were dispersed in an open 7 mm
quartz crucible.
Thermogravimetric analysis was performed with a Rheo-
metric Scientific STA 1500 apparatus. Temperature calibra-
tion was carried out using the values tabled for indium, tin
and lead. The heating run selected was 10 ◦C/min and the
purge was achieved by a 50 ml min−1 flow of dry nitrogen.
M.L.P. Leitão et al. / Thermochimica Acta 411 (2004) 53–60 55
A X-ray diffractometer (Philips 1830) was employed for
recording the X-ray pattern of the samples under study.
The powder diffraction spectra were obtained with a Cu
K1 source operating at a tube load of 40 kV and 30 mA.
Powder samples of particle size below 300m were packed
onto 16 mm diameter stainless steel holder and gently
pressed. Scans were accumulated over the range of 3–40◦
(2θ) with a step size of 0.02◦ (2θ) and the collection time
of 1 h. Counting was detected with a time constant of
1.25 s.
Fig. 1. Micrographs showing the solid state forms of terfenadine obtained by crystallization from solvents and the transformations observed by heating.
E–Wv, typical image of crystalline solid (type I). M2, phase transition in a type II specimen—40 ◦C, crystalline phase and amorphous material; 85 ◦C,
primitive crystalline phase and liquid; 140 ◦C, primitive and crystalline phase proceeding from molten. M4, phase transition in a type III specimen—40 ◦C,
methanol solvate; 70 ◦C, desolvated methanol solvate; 85 ◦C, molten solvate; 140 ◦C, crystalline solid phase arisen from the molten.
3. Characterization of terfenadine
3.1. Thermomicroscopy
Crystalline phases, amorphous solid material, and solvates
may be observed by thermal microscopy. Most specimens
show the presence of more than one of this kind of struc-
ture. According to the phases present, the specimens can be
included into three groups. One, denominated group I, in-
cludes specimens which, under polarized light observation
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shows elongated crystalline thermally stable aggregates;
another group, denoted by group II, is characterized by crys-
talline aggregates like those observed for I, and by particles
of irregular shape and various sizes which do not exhibit
light birefringence; that is, this group is characterized by
the coexistence of crystalline and amorphous phases. Fi-
nally, group III, consists mainly of amorphous solid, and
ethanol or methanol–solvate which appears as a low melting
crystalline phase. Small crystalline aggregates of the higher
melting crystalline phase are also observed in the specimens
included in this group. Terfenadine specimens labelled as
E1, E2, E2′, M1, E–W3 and E–Wv belong to the first group
(I). Those numbered as E3, M2 and M2′ are included in the
second (II) and E4, M3 and M4 are part of the third (III).
The microscopic observation of the samples submitted to
heating and cooling thermal runs gives valuable information
on their structures. Type I specimens do not show any phase
transformation when submitted to a heating run, but fusion
which takes place in 147–150 ◦C temperature range. The
melt gives rise on cooling to a glassy state as the temperature
reaches a value around 50 ◦C. No crystallization of the glass
is observed for years at room temperature.
On heating a group II specimen at 75 ◦C the amorphous
material becomes liquid; the supercooled liquid remains sta-
ble for hours if temperature does not exceed 80 ◦C, but on
further heating a slow crystallization process takes place in
the temperature interval between 90 and 120 ◦C. The final
solid phase has a melting point in the same range of tem-
perature as the specimens of the group I.
The specimens of group III exhibit still a more complex
pattern than that described for II. First, the transformation
of the solvate into amorphous state is observed just before
fusion. Although these two transitions take place in a nar-
row temperature interval, they can be well followed through
microscopy. Similarly to what happens with II specimens,
the supercooled liquid resulting from the amorphous solid
material recrystallizes. Regarding crystallization of the su-
percooled liquid on heating, a difference between groups II
and III is observed. In fact, for group II specimens the crys-
tallization is initiated at a lower temperature and is faster
than for group III. These differences may be understood on
the grounds of the composition. Whilst in group II the liquid
is in contact with the surface of a crystalline phase which
may act as nucleation sites, in group III the liquid is almost
a homogeneous system requiring higher energy for nucleus
formation [16,17].
The images presented in Fig. 1 illustrate the different
phases of terfenadine obtained from solvents and the transi-
tions in which they are involved during the heating process.
3.2. Differential thermal analysis
Differential thermal analysis curves following the heat-
ing process performed on the specimens under considera-
tion from 20 ◦C to fusion at a heating rate of 10 ◦C/min are
illustrated in Fig. 2. The three types of terfenadine obtained
Fig. 2. DTA curves shown by terfenadine crystallized from solution. I,
II and III are typical curves observed for the respective groups of solid
material described in the text.
from solution and described before can be characterized by
these curves. Type I specimens show only one endothermic
transition which corresponds to the fusion of the crystalline
phases formed in solution. As expected from the thermomi-
croscopic observations, the group II specimens show two
endothermic and one exothermic transitions. As the temper-
ature increases, the first endotherm regards the melting of
the amorphous solid, the exotherm, the crystallization of the
resulting liquid; and the second endotherm, the melting of
the phases originated from solution and from the amorphous
solid transformation. The pattern shown by group III speci-
mens is apparently identical to that of group II. However, two
differences should be pointed out. First, the lower tempera-
ture endotherm obtained for group III is a composed curve
which can be deconvoluted into two curves whose maxima
are at 63 and 70 ◦C. As explained before, the two overlapped
curves correspond to the transformation of the solvate into
amorphous (vide Fig. 3) and to the melting of this solid
form. Second, the exotherm of group III occurs at a higher
temperature and is wider than that obtained for group II.



















Fig. 3. TG patterns shown by terfenadine obtained from crystallization. The behavior of sample E1 is observed for all solids of group I or II. E4, M3,
and M4 are the patterns for the solids included in group III.
3.3. X-ray diffraction
X-ray diffraction studies on terfenadine, as far as we know
were only published by Blanchard [18] and by Hakanen and
Laine [14]. The former author did not mention the existence
of polymorphic forms whilst the authors of the second pa-
per give powder diffraction patterns for a high melting and
a low melting polymorph as well as for a methanol solvate.
The high melting form was prepared from ethanol, the low
melting one from acetone, and the solvate, from methanol.
The data published by Blanchard [18] are found in the In-
ternational Center of Diffraction Data under “i” mark clas-
sification and differ from all of those given by Hakanen and
Laine [14]. Therefore at this stage no reference is available
for the identification of terfenadine forms by X-ray diffrac-
tion, neither do we have methods for the preparation of
single well-defined polymorphs. Despite these gaps, X-ray
diffraction data are useful for determining the degree of crys-
tallinity of the specimens under consideration and for com-
paring their structures.
The specimens included in group I are composed of
crystalline phases. However, significant differences for the
relative intensity and for the peak positions are observed
between them. One type of pattern is observed for the spec-
imens prepared from ethanol (E1, E2, E2′, E3), another is
exhibited by the specimen prepared from methanol at 50 ◦C
(M1) and a third one characterizes the specimens obtained
from ethanol–water (E–W3 and E–Wv). The three types of
X-ray powder diffraction patterns are presented in Fig. 4.
Regarding the diffraction pictures obtained for the crys-
talline phases, we can not ascribe the differences between














Fig. 4. X-ray powder diffraction patterns of terfenadine grown in solution
illustrating the presence of crystalline, amorphous and solvate states. E1
and M1, crystalline solid phases; M2, crystalline and amorphous solid
phases; E4 and M4, ethanol and methanol solvates. E–Wv, crystalline
single phase.
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ferences may be due to mixtures of single solid phases.
Indeed the existence of concomitant polymorphs has been
reported for some systems [19]. Some more elements are
needed in order to decide whether the structures illustrated
by E1 and M1 are single or crystalline mixtures. The ele-
ments we have on the E–Wv specimen, lead to the conclu-
sion that it is a single polymorphic form [7].
The group of specimens denoted as II, due to the presence
of amorphous solid phase shows broad diffraction peaks as
observed for M2. The specimens of group III show broad
diffraction peaks due to the presence of amorphous solid
material and characteristic peaks of the solvates. The char-
acteristic line for the ethanol solvate is observed at 8.250◦
(2θ) and that for the methanol solvate at 10.165◦ (2θ).
Besides the evidence for crystalline, amorphous and sol-
vate states of terfenadine, X-ray diffraction points out the
existence of different polymorphs of this substance gener-
ated in solution.
4. Discussion
Crystalline, amorphous and solvates are solid phases ob-
tained in the crystallization of terfenadine using the proce-
dures described above. The nature of the solvent and the
temperature at which crystallization takes place play a role
in the structure of the solid state obtained. The increase of
the temperature tends to originate crystalline forms whereas
its decrease tends to give rise to amorphous and solvates.
The comparison of ethanol with methanol as solvent, at the
same temperature, gives evidence of the higher degree of
crystallinity of terfenadine precipitated from the former sol-
vent relatively to the later. Ethanol–water at room temper-
ature gives crystalline phases, whether the solidification is
by cooling or by vapour diffusion technique.
A deep insight into the crystallization process can be
reached by calorimetry. Indeed, the enthalpy of transferring
the solute molecule from the normal state of aggregation to
an infinite dilute solution, solH◦, provides valuable infor-
mation about solute–solvent intermolecular forces. The vari-
ation of solH with concentration is also a useful quantity
for following the formation of the solid phase from solution.
Data for these thermodynamic quantities for terfenadine in
ethanol, methanol and ethanol–water at 25 ◦C were given in
previous publications [20,21]. Thus, in the foregoing discus-
sion, we will refer the data quoted for these properties which
are inserted in Table 2. In the same table are displayed the
approximate values determined for the variation of solH
from a high-dilute to a saturated solution, (solH).
As shown in Table 2, the dissolution of crystalline terfe-
nadine in any of the solvents we are dealing with is an en-
dothermic process. A positive value found for solH◦ means
that the dissolution is accompanied not only by an increase
of the enthalpy but also by an increase of entropy, so that
the entropic term of Gibbs energy overcomes the enthalpic
one. Based on the values of solH◦ observed for the dif-
Table 2
Limit value of the enthalpy of solution of terfenadine in different solvents,
solH◦, and the variation of the enthalpy of solution from a dilute to a





Methanol 19.8 ± 0.13 1.9 ± 0.13
Ethanol 21.1 ± 0.28 0.8 ± 0.28
Ethanol:water (85:15, v/v) 24.6 ± 0.03 1.6 ± 0.06
Temperature 25 ◦C.
ferent solvents, we conclude that solute–solvent interaction
increases from ethanol–water to ethanol and from this to
methanol. This order was expected from the characteristic
properties of the liquids towards the solute structure. The
terfenadine molecule has three polar centres (the hydroxylic
groups and the nitrogen atom) and a large nonpolar part.
It can interact with dipolar protic solvents, as those we are
considering, mainly by hydrogen bonding involving solute
and solvent polar parts and by dispersion forces involving
nonpolar ones.
The higher dipole moment of methanol relatively to that
of ethanol and the higher molecular polarizability of the lat-
ter alcohol relatively to the former leads to the conclusion
that the interactions between solute and solvent polar sites
are stronger with methanol than with ethanol. On the con-
trary we expect that ethanol favours the interaction between
the nonpolar moieties of the solute and the solvent rela-
tively to methanol. The same conclusions are reached on
the grounds of the values tabled for the polarity index and
hydrogen bond donation or acceptance ability for these al-
cohols [22]. The molecular interaction between ethanol and
water weakens solute–solvent forces between co-solvent and
terfenadine. Indeed the effect of water on the decrease of
solute–solvent interaction can be seen in the solubility of the
terfenadine. The solubility of this substance in pure ethanol
at 298.15 K is 0.071± 0.0017 M whereas in ethanol–water
(85:15, v/v) at the same temperature it is 0.0221±0.00026 M
[23]. Spectroscopic data on alcohol rich solutions give evi-
dence of an ethanol–water interaction stronger than that of
ethanol–ethanol [24].
In short, from the values of solH◦ quoted for terfena-
dine in the solvents employed in the crystallization of this
substance, one can say that solvation is dominated by the
interaction of the solvent with the solute polar centres and
that this interaction decreases from methanol to ethanol and
to ethanol–water.
The variation of the enthalpy of solution with the con-
centration, giving information on solute–solute interaction,
is valuable for following the crystallization process in so-
lution. As can be seen in Fig. 1 of the paper by Canotilho
et al. [20], for all solvents, solH is positive and increases
as temperature increases. Rather different patterns of solH
versus molality curves are shown by ethanol relatively to
methanol and ethanol–water mixture. Whilst in ethanol the
increasing of solH is almost gradual, for the other media
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those curves exhibit a sudden increase as the concentration
reaches a value around 0.01 M. Very likely in ethanol the ter-
fenadine molecules are being incorporated in growing n-mer
aggregates. In the other solvents, a weak molecular associ-
ation occurs till the concentration reaches critical value and
an aggregate is then formed by an assortment of n solute
molecules.
Whatever the mechanism, on the thermodynamic point of
view, for all systems the enthalpy of solution is positive and
increases as the concentration increases. This means that
the molecular association of terfenadine in solution is an
endothermic and entropy driven process.
The assembling of a certain number of terfenadine
molecules to form the solid phase embryo can be schemat-
ically expressed by the following reaction
n(A : xS)→ An : yS+ (nx− y)S
A stands for terfenadine, S for solvent, x and y are the number
of solvent molecules involved in the monomer and in the
n-mer aggregate.
For the sake of simplifying the thermodynamic inter-
pretation, we can consider the global aggregation process
of the terfenadine in solution as composed of the follow-
ing three steps: desolvation of the monomeric terfenadine
molecule, self-assembling of desolvated terfenadine in
n-mers aggregates, aggregate–solvent interaction. The as-
sociation of desolvated terfenadine molecules as the result
of the forces set up between the solute molecules is en-
thalpy favourable and entropy unfavourable. On the other
hand, desolvation–solvation will give a positive contribu-
tion to the enthalpy and to the entropy because the number
of solvent molecules taking part in the monomer solvation
co-sphere affected by the molecular association is higher
than those attached to the aggregate. The positive values
obtained for (solH) means that the contribution to the
thermodynamic properties coming from the steps involving
the solvent overcomes that owing to the interaction be-
tween terfenadine molecules themselves; the solvent plays
a key role in the molecular aggregation. As a critical size
is reached, the terfenadine aggregates become nuclei of the
solid phase. Thence, the structure of this phase will depend
much on the structure of the aggregates.
Although the investigation of the molecular structure is
out of the scope of thermodynamics, some information can
be drawn from the solvation data presented above and from
the nature of the solids obtained from the solvents used in
crystallization. In fact, taking into account that increasing
temperature or decreasing solvent polarity improve terfe-
nadine crystallinity, one concludes that crystalline state is
formed in conditions favouring the desolvation of the terfe-
nadine as self-assembling takes place. Thence we can infer
that the nucleus originating the solid phase is composed of
unsolvated terfenadine molecules. Among the systems under
study this happens with ethanol–water and ethanol specially
at temperatures above 3 ◦C. At lower temperatures or in the
presence of solvents more strongly bonded to the polar cen-
tres of the solute, the aggregate is formed by solvated terfe-
nadine molecules. The interaction between the polar centres
of the solute blocked by the solvent is not relevant, result-
ing in a poorly ordered aggregate. Very likely this is what
happens with ethanol at 3 ◦C and methanol between 50 and
3 ◦C. At an even lower temperature a stronger interaction
between terfenadine and the solvent leads to its incorpora-
tion in a crystalline solid structure giving rise to solvates.
As expected from the solute–solvent interaction, these pseu-
dopolymorphs are easier to get from methanol than from
ethanol. This is what happens with ethanol below 3 ◦C and
methanol below 50 ◦C.
5. Conclusions
The systematic study on the crystallization of terfenadine
under different solvents and experimental conditions lead
to conclusions valid either for this compound or for other
organic compounds.
The structure of terfenadine in the solid state, like many
other organic crystal, is defined mainly by the hydrogen
bonds established between the molecular polar centres.
Thus, the results observed for terfenadine are valuable in-
formations for predicting crystallization outcomes of other
compounds, in particular, those containing nitrogen and
hydroxyl as polar groups. Many organic compounds of
biological interest have this type of groups.
Liquids as similar as ethanol and methanol under identi-
cal conditions give rise to terfenadine specimens of differ-
ent crystallinity degrees. Ethanol favours a higher crystalline
solid relatively to methanol. Temperature at which crystal-
lization is performed is a determinant factor on the structure
of the generated solid state. The crystalline state is favoured
by increasing the temperature. As temperature decreases the
amount of precipitated disordered material increases and at
lower temperatures formation of solvates take place.
These findings are explained on the grounds of the compe-
tition between solute/solvent and solute/solute interactions
as evidenced by solution thermodynamic properties.
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